SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-18-066051
Filing Date
2018-12-21
Accepted
2018-12-21 16:31:33
Documents
7
Effectiveness Date
2018-12-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tv509687_s8.htm S-8 39527
2 EXHIBIT 5.1 tv509687_ex5-1.htm EX-5.1 11371
3 EXHIBIT 23.1 tv509687_ex23-1.htm EX-23.1 2557
4 EXHIBIT 99.1 tv509687_ex99-1.htm EX-99.1 42067
5 GRAPHIC tv509687_img01.jpg GRAPHIC 16683
6 GRAPHIC tv509687_img03.jpg GRAPHIC 438
7 GRAPHIC tv509687_img02.jpg GRAPHIC 8085
  Complete submission text file 0001144204-18-066051.txt   131769
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228980 | Film No.: 181249935
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1